Literature DB >> 23494109

Pancreatic anastomotic leakage after pancreaticoduodenectomy. Risk factors, clinical predictors, and management (single center experience).

Ayman El Nakeeb1, Tarek Salah, Ahmad Sultan, Mohamed El Hemaly, Waleed Askr, Helmy Ezzat, Emad Hamdy, Ehab Atef, Ehab El Hanafy, Ahmed El-Geidie, Mohamed Abdel Wahab, Talaat Abdallah.   

Abstract

BACKGROUND: Postoperative pancreatic fistula (POPF) after pancreaticoduodenectomy (PD) remains a challenge even at high-volume centers.
METHODS: This study was designed to analyze perioperative risk factors for POPF after PD and evaluate the factors that predict the extent and severity of leak. Demographic data, preoperative, intraoperative, and postoperative variables were collected.
RESULTS: A total of 471 consecutive patients underwent PD in our center. Fifty-seven patients (12.1 %) developed a POPF of any type; 21 patients (4.5 %) had a fistula type A, 22 patients (4.7 %) had a fistula type B, and the remaining 14 patients (3 %) had a POPF type C. Cirrhotic liver (P = 0.05), BMI > 25 kg/m(2) (P = 0.0001), soft pancreas (P = 0.04), pancreatic duct diameter <3 mm (0.0001), pancreatic duct located <3 mm from the posterior border (P = 0.02) were significantly associated with POPF. With the multivariate analysis, both BMI and pancreatic duct diameter were demonstrated to be independent factors. The hospital mortality in this series was 11 patients (2.3 %), and the development of POPF type C was associated with a significantly increased mortality (7/14 patients). The following factors were predictors of clinically evident POPF: a postoperative day (POD) 1 and 5 drain amylase level >4,000 IU/L, WBC, pancreatic duct diameter <3 mm, and pancreatic texture.
CONCLUSIONS: Cirrhotic liver, BMI, soft pancreas, pancreatic duct diameter <3 mm, pancreatic duct near the posterior border are risk factors for development of POPF. In addition a drain amylase level >4,000 IU/L on POD 1 and 5, WBC, pancreatic duct diameter, pancreatic texture may be predictors of POPF B, C.

Entities:  

Mesh:

Year:  2013        PMID: 23494109     DOI: 10.1007/s00268-013-1998-5

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  56 in total

1.  Does pancreatic duct stenting decrease the rate of pancreatic fistula following pancreaticoduodenectomy? Results of a prospective randomized trial.

Authors:  Jordan M Winter; John L Cameron; Kurtis A Campbell; David C Chang; Taylor S Riall; Richard D Schulick; Michael A Choti; JoAnn Coleman; Mary B Hodgin; Patricia K Sauter; Christopher J Sonnenday; Christopher L Wolfgang; Michael R Marohn; Charles J Yeo
Journal:  J Gastrointest Surg       Date:  2006-11       Impact factor: 3.452

Review 2.  Association of preoperative biliary drainage with postoperative outcome following pancreaticoduodenectomy.

Authors:  S P Povoski; M S Karpeh; K C Conlon; L H Blumgart; M F Brennan
Journal:  Ann Surg       Date:  1999-08       Impact factor: 12.969

3.  Pancreatic juice output and amylase level in the drainage fluid after pancreatoduodenectomy in relation to leakage.

Authors:  Naoki Hashimoto; Harumasa Ohyanagi
Journal:  Hepatogastroenterology       Date:  2002 Mar-Apr

4.  Outcome of pancreaticoduodenectomy with pylorus preservation or with antrectomy in the treatment of chronic pancreatitis.

Authors:  R E Jimenez; C Fernandez-del Castillo; D W Rattner; Y Chang; A L Warshaw
Journal:  Ann Surg       Date:  2000-03       Impact factor: 12.969

Review 5.  Evolution and current status of the Whipple procedure: an update for gastroenterologists.

Authors:  S M Strasberg; J A Drebin; N J Soper
Journal:  Gastroenterology       Date:  1997-09       Impact factor: 22.682

6.  Risk factors and outcomes in postpancreaticoduodenectomy pancreaticocutaneous fistula.

Authors:  John W Lin; John L Cameron; Charles J Yeo; Taylor S Riall; Keith D Lillemoe
Journal:  J Gastrointest Surg       Date:  2004-12       Impact factor: 3.452

7.  Do preoperative biliary stents increase postpancreaticoduodenectomy complications?

Authors:  T A Sohn; C J Yeo; J L Cameron; H A Pitt; K D Lillemoe
Journal:  J Gastrointest Surg       Date:  2000 May-Jun       Impact factor: 3.452

8.  Impact of postoperative pancreatic fistula on surgical outcome--the need for a classification-driven risk management.

Authors:  Andreas Schmid Frymerman; Jochen Schuld; Patrick Ziehen; Otto Kollmar; Christoph Justinger; Marco Merai; Sven Richter; Martin Karl Schilling; Mohammed Reza Moussavian
Journal:  J Gastrointest Surg       Date:  2010-01-22       Impact factor: 3.452

9.  Optimal management of the pancreatic remnant after pancreaticoduodenectomy.

Authors:  S G Marcus; H Cohen; J H Ranson
Journal:  Ann Surg       Date:  1995-06       Impact factor: 12.969

10.  Pancreatic anastomotic leak after pancreaticoduodenectomy: incidence, significance, and management.

Authors:  J J Cullen; M G Sarr; D M Ilstrup
Journal:  Am J Surg       Date:  1994-10       Impact factor: 2.565

View more
  55 in total

1.  A New Feasible Technique for Polytetrafluoroethylene Suture Buttress-Reinforced Pancreaticojejunostomy (PBRP): Mechanical Analysis and a Prospective, Randomized Controlled Trial.

Authors:  Xinxin Shao; Yibin Xie; Quan Xu; Anqiang Sun; Zhenze Wang; Yantao Tian
Journal:  J Gastrointest Surg       Date:  2018-12-03       Impact factor: 3.452

2.  Pathologic Assessment of Pancreatic Fibrosis in Predicting Pancreatic Fistula and Management of Prophylactic Drain Removal After Pancreaticoduodenectomy.

Authors:  Xiaofei Lu; Yuxin Chen
Journal:  World J Surg       Date:  2016-06       Impact factor: 3.352

3.  Tobacco Smoking Associated With Increased Anastomotic Disruption Following Pancreaticoduodenectomy.

Authors:  Noah S Rozich; Alessandra Landmann; Casey S Butler; Morgan M Bonds; Laura E Fischer; Russell G Postier; Katherine T Morris
Journal:  J Surg Res       Date:  2018-08-31       Impact factor: 2.192

Review 4.  Impact of being overweight on the surgical outcomes of patients with gastric cancer: a meta-analysis.

Authors:  Xiang-Song Wu; Wen-Guang Wu; Mao-Lan Li; Jia-Hua Yang; Qi-Chen Ding; Lin Zhang; Jia-Sheng Mu; Jun Gu; Ping Dong; Jian-Hua Lu; Ying-Bin Liu
Journal:  World J Gastroenterol       Date:  2013-07-28       Impact factor: 5.742

5.  Preoperative Nutritional Assessment Using the Controlling Nutritional Status Score to Predict Pancreatic Fistula After Pancreaticoduodenectomy.

Authors:  Masashi Utsumi; Hideki Aoki; Seichi Nagahisa; Seitaro Nishimura; Yuta Une; Yuji Kimura; Fumitaka Taniguchi; Takashi Arata; Koh Katsuda; Kohji Tanakaya
Journal:  In Vivo       Date:  2020 Jul-Aug       Impact factor: 2.155

6.  Preoperative body mass index-to-prognostic nutritional index ratio predicts pancreatic fistula after pancreaticoduodenectomy.

Authors:  Norihiro Sato; Toshihisa Tamura; Noritaka Minagawa; Keiji Hirata
Journal:  Hepatobiliary Surg Nutr       Date:  2016-06       Impact factor: 7.293

7.  Pancreatico-duodenectomy and postoperative pancreatic fistula: risk factors and technical considerations in a specialized HPB center.

Authors:  Luciano De Carlis; Fabio Ferla; Stefano Di Sandro; Alessandro Giacomoni; Riccardo De Carlis; Raffaella Sguinzi
Journal:  Updates Surg       Date:  2014-04-22

8.  Does the Anatomy of the Transected Pancreatic Neck Influence Post Whipple's Operation Pancreatic Fistula?

Authors:  Nikhil S; P J Halder; Santhosh R; Ravindra N
Journal:  Indian J Surg Oncol       Date:  2018-05-11

9.  Pancreaticogastrostomy versus pancreaticojejunostomy reconstruction after pancreaticoduodenectomy: a meta-analysis of randomized controlled trials.

Authors:  Xianbin Zhang; Li Ma; Xiaohong Gao; Haidong Bao; Peng Liu; Ahsen- Aziz; Zhongyu Wang; Peng Gong
Journal:  Surg Today       Date:  2014-09-26       Impact factor: 2.549

10.  Isolated Roux loop pancreaticojejunostomy versus pancreaticogastrostomy after pancreaticoduodenectomy: a prospective randomized study.

Authors:  Ayman El Nakeeb; Emad Hamdy; Ahmad M Sultan; Tarek Salah; Waleed Askr; Helmy Ezzat; Mohamed Said; Mostaffa Abu Zeied; Tallat Abdallah
Journal:  HPB (Oxford)       Date:  2014-01-28       Impact factor: 3.647

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.